Evidera
David Franks is an experienced professional specializing in consulting skills training, leadership coaching, and organizational transformation. Currently, David provides consulting skills training at Wipro, Evidera, and Swiss Re, while also serving as Managing Director and owner of UICL since 1989, working with clients globally on strategy, leadership, and culture change. Previous roles include leadership coaching for Signet Jewelers and Flughafen Köln/Bonn GmbH, and extensive experience at Penguin Random House and BMO Financial Group in strategy and internal consulting training. David holds a Master of Arts in Chemistry from the University of Oxford and pursued further education at Stichting Opleiding Rebalancing.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.